EP
RGNX icon

Elkfork Partners’s Regenxbio RGNX Stock Holding History

Elkfork Partners’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$184K Buy
5,170
+374
+8% +$15.2K ﹤0.01% 842
2019
Q2 		$246K Hold
4,796
– – 0.01% 772
2019
Q1 		$275K Buy
4,796
+308
+7% +$15.3K 0.01% 727
2018
Q4 		$188K Buy
4,488
+814
+22% +$47.8K 0.01% 785
2018
Q3 		$277K Buy
3,674
+2,134
+139% +$154K 0.01% 765
2018
Q2 		$111K Buy
+1,540
New +$73.5K ﹤0.01% 906

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Elkfork Partners's RGNX Position: Q3 2019 in Review

Elkfork Partners increased its Regenxbio (RGNX) stake by 7.8% in Q3 2019, buying an estimated $15.2K and bringing the position to 5,170 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Elkfork Partners first reported a position in RGNX in Q2 2018 and has held it in 6 quarters since. The position peaked at $277K in Q3 2018. 168 funds tracked by Wall St. Rank hold RGNX as of Q3 2019.

  • Elkfork Partners held 5,170 shares of Regenxbio worth $184K as of Q3 2019.
  • Elkfork Partners bought 374 Regenxbio shares in Q3 2019, an estimated $15.2K.
  • Regenxbio made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #842 holding.
  • Elkfork Partners first reported a position in Regenxbio in Q2 2018 and has held it in 6 quarters since.
  • Elkfork Partners's Regenxbio position peaked at $277K in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Regenxbio as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.